Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rangering i aksjer #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Aksjekurs
$2.49
Markedsverdi
$4.47M
Endring (1 dag)
-4.01%
Endring (1 år)
678.16%
Land
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Kategori

EPS for BioNexus Gene Lab Corporation (BGLC)
EPS per September 2025 TTM: $-1.27
Ifølge de siste økonomiske rapportene og aksjekursen til BioNexus Gene Lab Corporation er selskapets nåværende EPS (TTM) $-1.27. Ved slutten av 2023 hadde selskapet en EPS på $-1.53, en økning sammenlignet med EPS-en i 2022 som var $-0.25.
EPS-historikk for BioNexus Gene Lab Corporation fra 2016 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-1.27 41.11%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.77 -1,499.21%
US
$5.07 -499.21%
US
$13.17 -1,137.01%
US
$0.74 -158.17%
CN
$4.54 -457.48%
US